Opinion
Video
A panelist discusses novel treatments for retinal vascular diseases, including faricimab, aflibercept, and port delivery system with ranibizumab.
Video content above is prompted by the following:
Could you briefly provide an overview of the new treatments available for retinal vascular diseases?
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.